Emtricitabine/Rilpivirine/Tenofovir alafenamide vs Entecavir
National NHS prescribing compared (Prescription Cost Analysis)
Entecavir was dispensed 279.0× as often as Emtricitabine/Rilpivirine/Tenofovir alafenamide in April 2026 — 279 items versus 1 in England.
1items
Emtricitabine/Rilpivirine/Tenofovir alafenamide · April 2026
NHSBSA Prescription Cost Analysis
279items
Entecavir · April 2026
NHSBSA Prescription Cost Analysis
Figure 1. Emtricitabine/Rilpivirine/Tenofovir alafenamide versus Entecavir: national items dispensed by month
▬ Emtricitabine/Rilpivirine/Tenofovir alafenamide · ╌ Entecavir
Source: NHSBSA Prescription Cost Analysis, to April 2026
| Measure | Emtricitabine/Rilpivirine/Tenofovir alafenamide | Entecavir |
|---|---|---|
| Items, April 2026 | 1 | 279 |
| Items, last 12 months | 3 | 3,325 |
| Net ingredient cost, April 2026 | £491 | £138,668 |
See the full profile for Emtricitabine/Rilpivirine/Tenofovir alafenamide or Entecavir.